Clinical Trial Results: Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of Hectorol in pediatric CKD stage 3-4 with secondary hyperparathyroidism; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Hectorol (doxercalciferol)

Snippet

Sponsor: Sanofi | Conditions: Secondary Hyperparathyroidism-Chronic Kidney Disease | Phase 3 | Status: TERMINATED | Results posted: 2026-07-02